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Abstract: Plasma total antioxidant (TAO)
levels, LDL (low density lipoprotein),
antioxidant defense potential (AOP) and the
resistance to oxidation of LDL fractions were
studied in chronic hemodialysis patients. The
differences with respect to dialyzer
membrane types before and after
hemodialysis were also assessed. After
isolation of LDL from plasma by precipitation,
AOP was measured based on the
determination of TBARS (thiobarbituric acid
reactive substance), and resistance to
oxidation was assessed by the metal-catalyzed
peroxidation of LDL followed by the
determination of the values of the
peroxidation product malondialdehide (MDA)
before and after peroxidation. The assay
principle of
TAO was based on the
suppression of ABTS+ radical cation (2,2’Azino-di- [3-ethylbenzthiazoline sulfonate])
by the sample. AOP and the resistance to
oxidation of LDL were expressed as 1/nmol/
ml.h. Plasma TAO levels of patients (n=22)
were significantly lower than those of the
control group (n=20). In the patient group,
the decrease in TAO levels was also significant
and continued to the end of the single dialysis
session. The rate of decrease was similar in
the two types of conventional membranes

Introduction
Chronic renal failure (CRF) is associated with an
increased risk of atherosclerotic cardiovascular disease
(1,2), which represents the major cause of mortality in
patients on long-term hemodialysis (2,3). A number of
factors contribute to accelerated atherogenesis in the
presence of renal failure, including hypertension, diabetes
and dyslipidemia. However, after taking the increased
prevalence of conventional risk factors into account, the
exact role it plays in the evolution of atherosclerosis
remains unclear partly due to the limitation of the
methodologies available to measure free-radical
generation in vivo (4).

used (polysulfone and hemophan). The
antioxidant defense potential of LDL
significantly decreased after hemodialysis
with the polysulfone type dialyzer but
resistance to oxidation values of LDL showed
no difference. When the same group of
patients were hemodialyzed with a vitamin E
bonded membrane no difference was
observed in the AOP of LDL, but resistance to
oxidation of the LDL fraction significantly
increased during the hemodialysis session.
The results suggest that the vitamin E-bonded
dialysis membrane strengthens the LDL
antioxidant defense potential and protects the
LDL from oxidation.
In conclusion, the decreased antioxidant
capacity in these patients may be attributed to
several factors such as elimination via the
dialyzer of enzymatic or nonenzymatic
antioxidants or deformation of these
compounds by the increased oxidant stress.
Improving LDL resistance to oxidation by
using a vitamin E-bonded membrane appears
to be an attractive alternative to prevent
accelerated
oxidative
processes
in
hemodialysis patients.
Key Words: Oxidative stress, hemodialysis,
antioxidants, LDL oxidation

Several reports suggest that uremia is a state of
oxidative stress. These include findings such as an
increase in lipid peroxides in uremic red blood cell
membranes (5) and a decrease in serum antioxidant
activity (6). The accumulation of lipid peroxidation
products in uremia may be the result of a number of
different factors. One possibility is uncontrolled radical
mediated lipid peroxidation during the hemodialysis
procedure. Neutrophils are activated at the surface of the
dialyzer membrane, which may cause the subsequent
release of oxygen radicals capable of oxidizing lipids.
Lipid peroxidation, specifically low-density lipoprotein
(LDL) oxidation, appears to be a critical step in the
pathogenesis of atherosclerotic vascular disease (1). The
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oxidation of polyunsaturated fatty acids within LDL is
followed by their breakdown and the release of aldehydes
and ketones, such as malondialdehyde and 4hydroxynonenal, which can modify lysine residues on
apolipoprotein B (apo B). Modified apo B is no longer
recognized by the apo B receptor, but instead is taken up
by the macrophage scavenger receptor. This leads to
unregulated uptake of LDL cholesterol and the formation
of foam cells, and eventually results in a fatty streak, the
first phase of an atherosclerotic lesion (3,7). High levels
of oxidized LDL have been reported in HD patients (8,9).
There are some conflicting reports on oxidative
modifications of the lipids in hemodialysis patients (8,9).
The relative heterogeneity of data published is probably
due to different factors including intra- and inter-patient
variability, selection of patients and different dialysis
methods, particularly those using various membranes
with different compositions.
Recently, the use of vitamin E-coated multilayer
dialysis membranes has been proposed to prevent ROS
(reactive oxygen species) production and improve
antioxidant host defense mechanisms (12). Markers of
oxidative stress such as lipid peroxidation product MDA
(10), advanced glycation end-products (AGE) (11),
advanced oxidation protein products (AOPP) (12) and
enhanced susceptibility to LDL oxidation (13) are elevated
in hemodialysis patients.
Several serum components act as antioxidants and
neutralize free radicals. Ascorbic acid, vitamin E, beta
carotene, and serum proteins are all antioxidants. Since
the antioxidant system has many components, a
deficiency of any component can cause a reduction in the
total antioxidant status of an individual. Thus, it is more
meaningful to assess the total antioxidant capacity of
serum using a single assay in a clinical laboratory rather
than measuring the individual components of the total
antioxidant system in serum. Automation of the
antioxidant assay has become available recently, and is
used in routine clinical laboratories due to the simplicity
and cost effectiveness of the automated technique.
The objective of the presented investigation was to
determine TAO activity in the sera of hemodialysis
patients by using an automated technique and to evaluate
the relation between LDL oxidation and hemodialysis with
respect to membrane types. Another aim was to evaluate
whether vitamin E-modified multilayer hemodialysis
membranes have an in vivo potential effect on protection
from LDL oxidation.
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Materials and Methods
Twenty-two nonsmoking patients receiving chronic
hemodialysis treatment for at least 12 months were
evaluated. The patients (n=22) were selected from those
who had been clinically stable for the previous 3 months
and were included in this study after receipt of informed
consent. End-stage renal disease developed secondary to
chronic tubulointerstitial nephritis (5 patients), chronic
glomerulonephritis (6 patients), polycystic kidney disease
(2 patients), and amyloidosis (1 patient). The other cases
(8 patients) were of unknown origin. All patients were
dialyzed three times a week for four hours in each
session, using a bicarbonate bath.
Our study was performed in two steps. In the first
step, TAO status together with the uric acid levels of the
sera obtained from the 22 hemodialysis patients were
determined. The differences between TAO and uric acid
values of pre- and post-dialysis session were evaluated
and compared with those of the control group. Because
TAO and uric acid levels decreased with the dialysis, these
two parameters were assessed in various membranes.
Eleven patients (first group) were selected from those
who used a polysulfone membrane (mean age= 39.2 ±
7.3, and 7 male, 4 female) and the other group of eleven
patients (second group) was selected from those who
used hemophan (mean age= 41.5 ± 8.8, and 6 male and
5 female) for hemodialysis. Both groups had similar age
and sex composition and had the same duration of
hemodialysis. Two weeks later, a vitamin E-bonded
membrane was used in the patients to whom the
polysulfone membrane was applied and the results were
compared with those of the polysulfone membrane
group.
To investigate whether decreased serum TAO activity
is related to LDL oxidation, the resistance to oxidation and
AOP of the LDL fraction with respect to membrane types
were assessed. Plasma samples were obtained from each
patient before and after hemodialysis for isolations of LDL
fractions.
All three kinds of dialyzer (low-flux dialyzer)
membranes were hollow fiber. The manufacturer of the
hemophan type membrane was Kawasumi Lab. Inc.
Tokyo, Japan; the manufacturer of the polysulfone type
membrane was Fresenius Medical Care, Hamburg,
Germany; and the manufacturer of the vitamin E-bonded
filters was Excebrane CL*E15-18L, Terumo, Japan. The
composition of these membranes was as follows:
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Hemophan:
Diethyleaminoethylcellulose,
potting
compound: polyurethane; Polysulfone: polycarbonate,
potting material: polyurethane; Excebrane: multilayer
structure of cellulose, acrylic/fluororesin copolymer, oleyl
alcohol and alpha-tocopherol.
Excluded from this study were subjects with diabetes
mellitus, chronic liver disease, malignancy, and acute
infections and those receiving multivitamin preparations
or vitamin E during the study. Duration of hemodialysis
treatment of the patients was (mean ± SD) 52.45 ± 34.6
months. Twenty nonsmoking healthy persons comprised
the control group (11 male, 9 female: mean age ± SD,
39 ± 28.6). Blood samples of healthy subjects and of HD
patients just before and after the dialysis were used in
accordance with the policies and regulations of local
ethical committees.
Blood Routine Parameters: Uric acid, total
cholesterol, HDL-cholesterol, LDL-cholesterol, and
triglyceride were assayed in a Synchron CX7 (BeckmanCoulter CA, USA) by routine enzymatic methods.
Apolipoprotein and lipoprotein-a examinations were
performed by the immunonephelometric assay (BeckmanCoulter, CA, USA).
Measurement of Total Antioxidant Status: The
reagents of Total Antioxidant Status were supplied from
Randox (Antrim, UK). The assay principle wasbased on
the suppression of ABTS+ radical cation (2,2’-Azino-di[3-ethylbenzthiazoline sulfonate]) by the antioxidant
content of the sample. The assay procedure of the
reactive was adapted to an RA-XT (Tarrytown, NY, USA)
autoanalyzer. TAO statuses were expressed as mmol/L.
AOP and Resistance to Oxidation of LDL Fraction:
Determinations were performed before and after the
dialysis session in all groups.
LDL Preparation: LDL isolated from 1 ml EDTA
plasma within 6 ml 64 mM citrate buffer containing
50,000 IU/L sodium heparin was precipitated by
centrifugation as described previously (14). The
precipitated pellet was resuspended in 1 ml PBS
(phosphate buffered saline, pH 7.3) and then used for
antioxidant defense potential (AOP) and resistance to
oxidation of the LDL fraction.
Measurement of RO: Resistance to oxidation was
assessed as described by Dasgupta et al. (15). This assay
is based on the determination of malondialdehyde (MDA)
with thiobarbituric acid assay levels before and after 24 h

incubation with copper-II sulfate by incubation with
metal-catalyzed peroxidation, and then the peroxidation
products of the LDL fraction were measured. Levels of
MDA (nmol/ml sample/24h) are inversely proportional to
resistance to oxidation. To obtain a positive proportion,
the results were converted to 1/nmol/ml.h.
Assessment of Antioxidant Potential: AOP was
assessed as described by Durak et al. (16), which is based
on the determination of TBARS levels in fish oil (0.2 µl
per ml) enriched sample medium before and after
exposure to superoxide radicals (O2-.) produced by
xanthine (10 mM)/xanthine oxidase (0.012 U) system.
For this purpose, TBARS levels in the reaction mixture
were measured before and after the radical attack. The
difference between the values was inversely proportional
to the AOP of the samples. The AOP was assessed from
the difference between TBARS levels of a blank and a
sample studied and the results were expressed as
nmol/ml/h.
Statistical analysis: Student’s t and paired t-tests
were used to compare the results and Spearman
correlation analysis was used for the correlation
calculation.

Results
The biochemical characteristics of the patients during
the prehemodialysis period are shown in Table 1. Our
results showed that the serum TAO status of the patient
group was significantly lower (1.355 ± 6.7, n= 22) than
that of the control group (1.60 ± 0.12, n= 20) (p<
0.001) and also showed a significant decrease after
dialysis (p< 0.001). Similarly, uric acid values decreased
significantly after dialysis (Table 2). When we
investigated the difference in activity in two types of
conventional membranes, there was no significant
difference in activity of TAO (Table 3).
In the patients to whom the polysulfone type dialyzer
was applied, the AOP of LDL showed a significant
decrease (p< 0.01). In this group, although not
statistically significant, the resistance to oxidation (RO) of
LDL decreased after hemodialysis (Table 4). In contrast to
these findings, when the vitamin E-bonded membrane
was applied to the same group, while there was no
difference in the results of AOP, a significant increase
with the dialysis session was detected in the results of the
resistance to oxidation of LDL (Table 5). As a result, a
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Table 1.

Table 5.

Biochemical characteristics of the patients.
Patients (n=22)

AOP and RO of LDL fraction in the same group of HD
patients (n=11) before & after HD using vitamin E-bonded
membrane.

MEAN ± SD
Age

43.3 ± 12.7

Duration of HD (months)

52.45 ± 34.6

Total cholesterol (mg/dl)

173.2 ± 39.5

HDL-Cholesterol (mg/dl)

38.6 ± 7.8
99.6 ± 25.2

(g/L)

0.98 ± 0.21

Apo-B

(g/L)

0.77 ± 0.23

Lipo-a

(g/L)

0.32 ± 0.19

Triglyceride

(mg/dl)

151.5 ± 70.6

Before HD
Mean ± SD

After HD
Mean ± SD

p value

TAO (mmol/L)

1.355 ± 6.7

1.238 ± 0.13

p < 0.001

UA (mmol/L)

0.305 ± 0.05

0.128 ± 0.07

p < 0.001

Comparison of serum TAO (mmol/L) with respect to
membrane types.
Before HD

After HD

Polysulfone (n= 11)

1.35 ± 8.6

1.24 ± 8.3

Hemophan (n= 11)

1.36 ± 4.3

1.23 ± 0.16

Paired t-test
p

Table 4.

Before HD
After HD

p > 0.05

p > 0.05

AOP and RO of LDL fractions in HD patients (n= 11) during
HD procedure using Polysulfone type dialyzer.
AOP ( /nmol/ ml.h)

RO ( / nmol/ ml.h)

42.5 ± 7.51

1.45 ± 0.83

32.96 ± 4.71

1.19 ± 0.48

Paired t-test
p
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p<0.01

27.22 ± 6.95

1.58 ± 0.11

After HD

29.91 ± 5.5

2.22 ± 0.14

p > 0.05

p < 0.01

vitamin E-bonded membrane may be considered a more
suitable medium with respect to oxidant stress because of
the increase in the resistance to oxidation in LDL.

TAO and UA levels of sera in patients (n= 22) before and
after HD.

Membrane types

Before HD

p

(mg/dl)

Apo-A

Table 3.

RO ( / nmol/ml.h)

Paired t-test

LDL-Cholesterol

Table 2.

AOP ( / nmol/ ml.h)

p >0.05

The correlation of the decrease in uric acid levels with
the TAO was found to be significant before hemodialysis
(r= 0.535, p=0.01) and moderate after hemodialysis (r=
0.405, p= 0.06). A significant inverse correlation was
also observed between serum LDL and TAO level (r= 0.429, p= 0.046).

Discussion
Oxidative stress has recently been implicated in the
progression of renal diseases (17,18) and there is
increasing evidence that the oxygen radical scavenger
system is severely impaired in patients on chronic
hemodialysis therapy (19-22) with a chronic deficiency in
the major antioxidant systems (23,24). Increased
oxidative metabolism in blood granulocytes has been
described both in end-stage renal failure (ESRF) and
hemodialysis patients (25). The generation of oxidized
low-density lipoprotein (ox-LDL) is a common feature of
oxidative stress, and high levels of ox-LDL have been
reported in hemodialysis patients (26,27).
It has been reported in several studies that serum
concentrations of superoxide dismutase, catalase and
glutation peroxidase, which are antioxidant enzymes,
decreased and lipid peroxidation by products such as
malondialdehyde MDA increased in hemodialysis patients
(14,25,28). Our findings may contribute to evaluations
of the decreased efficiency of the cellular defense
mechanism against ROS.
Hemodialysis was considered to aggravate the
uremia-related pro-oxidant/antioxidant imbalance. This
may result from increased ROS levels generated by
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circulating neutrophils when they enter into contact with
dialysis membranes. The dialysis membrane is subjected
to immunologic response by low molecular weight
plasma constituents such as IgG and complement
components to make the membrane biologically active
for granulocytes. Activation of blood granulocytes can
increase reactive oxygen species (29). The second
possible reason for the continuing decrease antioxidant
response after hemodialysis may be the removal of an
uremic inhibitor by dialysis. This suggests that an uremic
dialyzable inhibitor could be partly responsible for the
impaired TAO activity observed. However, it is also
possible that post-translational modification of the
constituents of TAO and AOP could contribute to
impaired activity. A number of modifications are
possible, including glycation, oxidation and
carbamylation. A loss through the dialysis membrane of
hydrosoluble antioxidants such as ascorbic acid, together
with their possible increased consumption by oxidation,
and other factors such as the absence of a complete
correction of the uremic toxicity, malnutrition and the
progressive worsening of the clinical condition due to
aging and comorbidity may contribute to a decreased
antioxidant power of plasma during dialysis.
Up to now it has been demonstrated that enhanced
susceptibility to LDL oxidation is found (13) and smalldense LDL subtractions, recognized for their enhanced
susceptibility to oxidation, have been shown in
hemodialysis patients (30).
Because of the great interest in the evaluation of the
role of ox-LDL in the atherosclerosis process, the TAO of
plasma, AOP and the resistance to oxidation of LDL have
to be investigated.
Several researchers suggested that plasma TAO would
be impaired in patients with ESRD (10); nevertheless,
other investigators found that plasma TAO activities were
higher in hemodialysis patients than in controls, and
decreased by the end of dialysis session. These
observations were attributed to uric acid, which was
present at a high concentration in plasma before dialysis;
thereby, it was termed the uric acid paradox (31). In
contrast to these observations, the activity was lower
than that of the controls before dialysis by automated
TAO technique. However, in our study cases, plasma uric
acid concentrations were within the normal limits before
dialysis and decreased significantly after dialysis together
with the decrease in plasma TAO. In our opinion, before

making a decision, the types of assay method should be
evaluated in detail.
Some authors showed that a cellulose membrane was
responsible for an acute stimulation of the oxidative
metabolism of leucocytes while a synthetic membrane
was able to reduce it (32).
According to our results, after dialyses plasma TAO
activity showed no difference with respect to standard
polysulfone and hemophan type membranes. Although
Cu+2 –induced oxidation of LDL fractions showed no
difference, the AOP of LDL decreased after the dialysis
session. This might have been caused by the high content
of advanced oxidation protein products in the LDL
fraction, which are more avid than native proteins for
trapping radicals or enrichment of LDL with triglycerides
(33,34). However, to clarify these hypotheses, further
research is needed.
In recent years, new approaches to antioxidant
therapy such as hemolipodialysis, infusion of antioxidants
by dialyzate, and vitamin E-bonded membranes in
hemodialysis have been introduced (34,37). The newest
scientific work in this field is based on the detailed
characterization of the multilayer structure and
composition of the vitamin E-bonded membrane (35-38).
Several investigations have shown that these membranes
can improve some antioxidant parameters (12), and
lower lipid peroxidation both in vitro and in vivo (10,38),
and decrease advanced glycation end-product (AGE)
accumulation (31).
The cellular functions of vitamin E have recently been
demonstrated in blood cells including a decreased
production of superoxide anion by activated monocytes
and polymorphonuclear leukocytes (39). Since ROS
production is enhanced during the dialysis session, this
cell-mediated action of vitamin E should be taken into
account in the beneficial action of vitamin E
supplementation in hemodialysis patients. Raggi et al.
observed in an in vitro study that a vitamin E-modified
membrane may offer some advantages compared to a
polysulfone membrane in inducing less oxidative stress in
granulocytes, resulting in a smaller production of oxygen
free radicals (40).
The present study confirms earlier reports describing
profound alterations in the circulating antioxidant levels
of patients with ESRD undergoing chronic hemodialysis
therapy. The aggravation of the antioxidant deficit as a
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result of a single dialysis session indicates that part of the
stress occurs during the dialysis procedure. The decrease
in both TAO and AOP suggests that the defense system
against the oxidant stress is insufficient and decreased
resistance to the oxidation of LDL may contribute to this
condition in hemodialysis with conventional membranes.
However, the AOP of LDL did not change in dialysis with
the vitamin E-bonded membrane, whereas a significant
decrease occurred with the standard polysulfone
membrane in the same patient group. This finding
indicates that the use of vitamin E-bonded membrane at
least in part may be beneficial by compensating for the
decrease in antioxidant potential and the increase in the
resistance to the oxidation of the LDL fraction during
dialysis. On the other hand, we postulate to assess the
total antioxidant status instead of assaying each
constituent separately to evaluate an individual’s defense
mechanism against the reactive oxygen species. This test
procedure is automated, convenient and available for use
in most analyzers.
In light of our results, improving LDL resistance to
oxidation by using a vitamin E-bonded membrane appears
to be an attractive alternative to prevent accelerated
oxidative processes in hemodialysis patients.
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Abbreviations
ABTS+

Radical cation (2,2’-Azino-di- [3-ethylbenzthiazoline
sulfonate])
AGE
Advanced glycation end-products
AOP
Antioxidant defence potential
AOPP
Advanced oxidation protein products
apo B
Apolipoprotein B
Apo-A Apolipoprotein A
CRF
Chronic renal failure
ESRD
End-stage renal failure
ESRF
End-stage renal failure
GSH-Px Glutathione peroxidase
HD
Hemodialysis
LDL
Low-density lipoprotein
MDA
Malondialdehyde
ox-LDL oxidized low-density lipoprotein
PBS
Phosphate buffered saline
RO
Resistance to oxidation
ROS
Reactive oxygen species
SOD
Superoxide dismutase
TAO
Plasma total antioxidant
TBARS Thiobarbituric acid reactive substance
UA
Uric acid
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